- US12259380utility2025Oligonucleotides for Inducing Paternal UBE3A Expression0 cites
- US12260944utility2025Drug Dosage Determination Devices and Methods0 cites
- US12252484utility2025Pyrazolopyridine Compounds for the Treatment of Autoimmune Disease0 cites
- US12252533utility2025Anti-transferrin Receptor Antibodies with Tailored Affinity0 cites
- US12252549utility2025Pertuzumab Plus Trastuzumab Fixed Dose Combination0 cites
- US12247036utility2025Tricyclic Compounds for the Treatment of Cancer0 cites
- US12239817utility2025Apparatus for and Method in Direct Drug Infusion Using a Label as a Hanger0 cites
- US12240911utility2025Bispecific Antibodies Specific for OX400 cites
- US12227594utility2025Bispecific 2+1 Contorsbodies0 cites
- US12221420utility2025Process for the Preparation of Substituted Pyrazole Derivatives0 cites
- US12215155utility2025Antibodies Binding to CD3 and CD190 cites
- US12215152utility2025Humanized Anti-human CD19 Antibodies and Methods of Use0 cites
- US12208142utility2025Process for Providing Pegylated Protein Composition0 cites
- US12209091utility2025Isoindolinone Derivatives as Selective Allosteric Inhibitors of Egfr Mutant Cancers0 cites
- US12202870utility2025Antigen Binding Molecules Comprising a Trimeric TNF Family Ligand and Encoding Polynucleotides Thereof0 cites
- US12203071utility2025Oligonucleotide Agonists Targeting Progranulin0 cites
- US12205720utility2025Digital Qualimetric Biomarkers for Cognition and Movement Diseases or Disorders0 cites
- US12195413utility2025Ethynyl Derivatives0 cites